Abstract
Objectives
This study aimed to investigate the incidence rate and spectrum of gene mutations of Glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Huizhou city of southern China to provide a scientific basis for disease prevention and control in the area.
Methods
From March 2003 to December 2022, newborn screening for G6PD enzyme activity was carried out in Huizhou city using the fluorescence quantitative method. Infants who tested positive during the initial screening were diagnosed using the nitroblue tetrazolium ratio method, while a subset of infants received further gene mutation analysis using the multicolor probe melting curve analysis method.
Results
A total of 1,291,274 newborns were screened and the screening rate has increased from 20.39% to almost 100%. In the 20-year period, 57,217 (4.43%) infants testing positive during the initial screening. Out of these infants, 49,779 (87%) were recalled for confirmatory testing. G6PD deficiency was confirmed in 39,261 of the recalled infants, indicating a positive predictive value of 78.87%. The estimated incidence rate of G6PD deficiency in the region was 3.49%, which was significantly higher than the average incidence rate of 2.1% in southern China. On the other hand, seven pathogenic G6PD variants were identified in the analysis of the 99 diagnosed infants with the most common being c.1388 G > A (48.5%), followed by c.95 A > G (19.2%), c.1376 G > T (15.2%), c.871 G > A (9.1%), c.1360 C > T (3.0%), c.392 G > T (3.0%), and c.487 G > A (1.0%).
Conclusion
The incidence of G6PD deficiency in newborns in the Huizhou city was higher than the southern China average level, while the types and frequencies of gene mutations were found to vary slightly from other regions. Our findings suggested that free government screening and nearby diagnosis strategies could reduce the incidence of G6PD deficiency in the area.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available on request from the corresponding author. Due to restrictions imposed by the Institutional Review Board (IRB) and the ethical considerations surrounding participant privacy, the dataset cannot be publicly shared. Interested researchers may contact the corresponding author to request access to the data. Requests will be reviewed by the research team and, if approved, data access will be provided following the completion of the necessary data sharing agreement.
References
Blanquicett CJ, Raavi T, Robert SM (2019) A Severe Episode of Hemolytic Anemia After Amoxicillin Exposure in A G6PD Deficient Patient. Arch Clin Med Case Rep 3:104–12. https://doi.org/10.26502/acmcr.96550068
Chen X, Yang L, Wang HJ, Wu BB, Lu YL, Dong XR et al (2018) Phenotypic and genotypic spectra of patients with glucose-6-phosphate dehydrogenase deficiency gene known pathogenic variants: a single-center study. Zhonghua Er Ke Za Zhi Chin J Pediatr 56:364–8. (https://pubmed.ncbi.nlm.nih.gov/29783823/)
Tang F, Tang CF, Jiang X, Jia XF, Liu SC, Chen QY et al (2020) Correlation analysis of genotypes and the enzymatic activities of glucose-6-phosphate dehydrogenase in neonates in Guangzhou. Zhonghua Yu Fang Yi Xue Za Zhi 54:1275–1282. https://doi.org/10.3760/cma.j.cn112150-20200611-00864
Anderle A, Bancone G, Domingo GJ, Gerth-Guyette E, Pal S, Satyagraha AW (2018) Point-of-Care Testing for G6PD Deficiency: Opportunities for Screening. Int J Neonatal Screen 4:34. https://doi.org/10.3390/ijns4040034
Lee HY, Ithnin A, Azma RZ, Othman A, Salvador A, Cheah FC (2022) Glucose-6-Phosphate Dehydrogenase Deficiency and Neonatal Hyperbilirubinemia: Insights on Pathophysiology, Diagnosis, and Gene Variants in Disease Heterogeneity. Front Pediatr 10:875877. https://doi.org/10.3389/fped.2022.875877
Tian X, Zhou J, Zhao Y, Cheng Z, Song W, Sun Y et al (2017) High-Throughput, Multiplex Genotyping Directly from Blood or Dried Blood Spot without DNA Extraction for the Screening of Multiple G6PD Gene Variants at Risk for Drug-Induced Hemolysis. J Mol Diagn 19:638–650. https://doi.org/10.1016/j.jmoldx.2017.05.007
Liu Z, Yu C, Li Q, Cai R, Qu Y, Wang W et al (2020) Chinese newborn screening for the incidence of G6PD deficiency and variant of G6PD gene from 2013 to 2017. Hum Mutat 41:212–221. https://doi.org/10.1002/humu.23911
Peng Q, Li S, Ma K, Li W, Ma Q, He X et al (2015) Large Cohort Screening of G6PD Deficiency and the Mutational Spectrum in the Dongguan District in Southern China. PLoS ONE 10:e0120683. https://doi.org/10.1371/journal.pone.0120683
Tong Y, Liu B, Zheng H, Bao A, Wu Z, Gu J et al (2020) A novel G6PD deleterious variant identified in three families with severe glucose-6-phosphate dehydrogenase deficiency. BMC Med Genet 21:150. https://doi.org/10.1186/s12881-020-01090-2
Wang X, Xia Z, He Y, Zhou X, Zhang H, Gao C, et al. (2021) Newborn Screening for G6PD Deficiency in Xiamen, China: Prevalence, Variant Spectrum, and Genotype-Phenotype Correlations. Front Genet 12:718503. https://doi.org/10.3389/fgene.2021.718503
Galatas B, Mabote L, Simone W, Matambisso G, Nhamussua L, Mañú-Pereira MDM et al (2017) Heterogeneity of G6PD deficiency prevalence in Mozambique: a school-based cross-sectional survey in three different regions. Malar J 16:36. https://doi.org/10.1186/s12936-016-1674-y
He Y, Zhang Y, Chen X, Wang Q, Ling L, Xu Y (2020) Glucose-6-phosphate dehydrogenase deficiency in the Han Chinese population: molecular characterization and genotype–phenotype association throughout an activity distribution. Sci Rep 10:17106. https://doi.org/10.1038/s41598-020-74200-y
Pan J, Zhuang D, Yu Q, Pan X, Bao Y, Pan S et al (2021) Molecular genotyping of G6PD mutations for neonates in Ningbo area. J Clin Lab Anal 35:e24104. https://doi.org/10.1002/jcla.24104
Nuinoon M, Krithong R, Pramtong S, Sasuk P, Ngeaiad C, Chaimusik S et al (2022) Prevalence of G6PD deficiency and G6PD variants amongst the southern Thai population. PeerJ 10:e14208. https://doi.org/10.7717/peerj.14208
Arain YH, Bhutani VK (2014) Prevention of Kernicterus in South Asia: role of neonatal G6PD deficiency and its identification. Indian J Pediatr 81:599–607. https://doi.org/10.1007/s12098-014-1410-y
Jiang W, Yu G, Liu P, Geng Q, Chen L, Lin Q et al (2006) Structure and function of glucose-6-phosphate dehydrogenase-deficient variants in Chinese population. Hum Genet 119:463–478. https://doi.org/10.1007/s00439-005-0126-5
Wei H, Wang C, Huang W, He L, Liu Y, Huang H, et al. (2023) Simultaneous detection of G6PD mutations using SNPscan in a multiethnic minority area of Southwestern China. Front Genet 13:1000290. https://doi.org/10.3389/fgene.2022.1000290
He M, Lin K, Huang Y, Zhou L, Yang Q, Li S et al (2018) Prevalence and Molecular Study of G6PD Deficiency in the Dai and Jingpo Ethnic Groups in the Dehong Prefecture of the Yunnan Province. Hum Hered 83:55–64. https://doi.org/10.1159/000489009
Hu R, Lin M, Ye J, Zheng B-P, Jiang L-X, Zhu J-J et al (2015) Molecular epidemiological investigation of G6PD deficiency by a gene chip among Chinese Hakka of southern Jiangxi province. Int J Clin Exp Pathol 8:15013–15018
Zhang XF, Tian GL, Ji W, Zhou Z, Guo J, Wang YM (2022) Clinical value and gene mutation analysis of fluorescence quantitative method and G6PD/6PGD ratio method in the diagnosis of glucose-6-phosphate dehydrogenase deficiency. Zhonghua Yi Xue Jian Yan Za Zhi 45:522–7. https://rs.yiigle.com/cmaid/1378051
Ji W, Tian GL (2022) Feasibility of indirect method to establish the cut-off value of neonatal G6PD screening in Shanghai. Jian Yan Yi Xue 37:112. https://doi.org/10.3969/j.issn.1673-8640.2022.02.003
Xu X, Lu G (2007) Clinical genetic consultation. Peking university medical press, Beijing
Xu D-D, Wen F-Q, Lv R-Y, Zhang M, Chen Y-S, Chen X-W (2016) Gene promoter methylation in glucose-6-phosphate dehydrogenase deficiency. Zhongguo Dang Dai Er Ke Za Zhi Chin J Contemp Pediatr 18:405–9. (https://pubmed.ncbi.nlm.nih.gov/27165588/)
Xia Z, Wang X, Ye H, Gao C, Zhou X, Chen J, et al. (2022) Evaluation of strategies for identification of infants with pathogenic glucose-6-phosphate dehydrogenase variants in China. Front Genet 13:844381. https://doi.org/10.3389/fgene.2022.844381
Suresh GK, Clark RE (2004) Cost-effectiveness of strategies that are intended to prevent kernicterus in newborn infants. Pediatrics 114:917–924. https://doi.org/10.1542/peds.2004-0899
Chu CS, Bancone G, Kelley M, Advani N, Domingo GJ, Cutiongo-de la Paz EM et al (2020) Optimizing G6PD testing for Plasmodium vivax case management and beyond: why sex, counseling, and community engagement matter. Wellcome Open Res 5:21
Acknowledgements
We would like to express our sincere gratitude to the organizations and individuals who generously provided the data for this study. Without their support and collaboration, this research would not have been possible. Additionally, we extend our appreciation to the funding agencies that have supported this work. Their financial contributions have played a crucial role in the successful completion of this study.
Funding
This work was supported by grants from Shenzhen Science and Technology Innovations Committee (No. JCYJ20180507183428877), Shenzhen Rare Disease Engineering Research Center of Metabolomics in Precision Medicine (F-2020-Z99-502,615). The funding organizations played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
Author information
Authors and Affiliations
Contributions
Zhiqiang Zhang and Xiaoting Wang contributed equally to this work. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhang, Z., Wang, X. & Jiang, J. Screening results and mutation frequency analysis of G6PD deficiency in 1,291,274 newborns in Huizhou, China: a twenty-year experience. Ann Hematol 103, 29–36 (2024). https://doi.org/10.1007/s00277-023-05533-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-023-05533-7